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A large amount of data has accumulated during the past 20
years demonstrating the value of exercise or pharmacologic
stress planar and single-photon emission-computed tomo-
graphic (SPECT) perfusion imaging for risk stratification
and prognostication in patients with suspected or known
coronary artery disease (CAD) (1–14). The major goal of
such noninvasive risk assessment is the identification of
subsets of patients at high risk for subsequent cardiac death
or nonfatal infarction who may benefit from prompt referral
for cardiac catheterization with a view toward invasive
strategies for revascularization (15). Conversely, patients
deemed at low risk for subsequent cardiac events based on
stress test and nuclear scan variables are treated medically
and spared the premature or unnecessary referral for invasive
evaluation, which also increases unduly the cost of diagnos-
tic cardiology.
See pages 194 and 200
Another specific objective of the addition of perfusion
imaging to conventional stress testing is to minimize the
number of patients who are still classified as intermediate
risk after the completion of testing (14,16). A significant
limitation of symptom-limited treadmill testing, even when
the Duke treadmill score (DTS) is used for risk separation,
is that a substantial number of patients are still deemed at
intermediate risk for subsequent cardiac death and nonfatal
ischemic events. When they are further risk-stratified by
exercise SPECT, those with normal scans have excellent
outcomes (14–17).
Perhaps the most valuable contribution of exercise or
pharmacologic myocardial perfusion imaging (MPI) is its
excellent negative predictive value for predicting a low
combined cardiac death and nonfatal myocardial infarction
(MI) rate in patients with a totally normal scan (1,12,18,19).
In a pooled analysis of 20,963 patients from 16 published
studies in the literature with a follow-up of slightly more
than two years, the hard event rate was 0.7%/year (1). This
compares to a hard event rate in the range of 7% in patients
with abnormal scans (3). Numerous studies have shown the
incremental value of stress MPI variables over clinical and
electrocardiographic (ECG) stress test variables for assess-
ing prognosis (1,2). The event rate increases in proportion
to either the extent of stress-induced hypoperfusion or the
extent of defect reversibility indicative of an ischemic
response. Other high-risk findings contributing to the
prediction of an increased cardiac event rate are transient
ischemic cavity dilation from stress-to-rest images (20),
extent of regional wall thickening or wall motion abnormal-
ities on gated SPECT, the ejection fraction and end-systolic
and end-diastolic volumes measured on gated SPECT, and
the extent of post-stress reversible regional dysfunction
reflective of myocardial stunning (21–26). Patients at high-
est risk for subsequent events are those with a low resting
left ventricular ejection fraction (LVEF) with associated
moderate or severe stress-induced reversible perfusion ab-
normalities (26). Similarly, patients exhibiting poor exercise
tolerance have a worse prognosis than patients with good
exercise tolerance (27,28). Patients at the lowest risk for
subsequent cardiac events are those who demonstrate good
exercise tolerance by being able to achieve 85% of maxi-
mum predicted heart rate for age with a normal perfusion
pattern on SPECT images (29).
The American College of Cardiology/American Heart
Association (ACC/AHA) practice guidelines for evaluating
patients with stable chest pain indicate that exercise stress
ECG should be the initial test performed in patients with a
normal ECG who are deemed able to adequately exercise
(30). Patients with a high pretest likelihood of CAD are
often referred directly to cardiac catheterization for diag-
nostic coronary angiography even if stable and no acute
coronary syndrome is identified.
In this issue of the Journal, two reports are published that
address the issue of whether MPI is a useful addition to the
workup of certain subsets of patients (31,32). Poornima et
al. (31) propose a rule-based strategy using a clinical score to
decide which patients at low risk after exercise ECG stress
testing (i.e., low DTS) would be most likely to benefit from
the addition of MPI for further risk stratification.
Hachamovitch et al. (32) examined whether it is of value
and cost-effective to use MPI for risk stratification of
patients with a 85% pretest likelihood of having CAD.
Diagnostic testing in patients having a low likelihood of
CAD is problematic for a number reasons. The low yield of
CAD detection results in poor cost-effectiveness. Aside
from cost issues, there are other negatives to consider. If the
probability of CAD is less than the false-positive rate of the
test, then most positive tests will be false positives. Such
false-positive tests have negative psychologic and negative
medical impact. Also, the significance of a true positive test
might be discounted when it is an unexpected result in a
setting where positive results are usually false positive.
Unfortunately, no single test for CAD is currently available
that provides optimal screening for patients with a low
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probability of CAD. Individuals with very low statistical
probability of CAD are rarely tested for CAD. However,
the population is very large, so even the rarely encountered
need to rule out CAD in individuals from this population
will result in a substantial number of referrals. Poornima et
al. (31) recognize that, although ACC/AHA guidelines call
for exercise stress testing as the initial diagnostic test for
patients with normal resting ECGs, a normal stress ECG
may not always provide adequate reassurance of the absence
of CAD.
Poornima et al. (31) examined 1,461 patients with a low
DTS and applied a clinical score developed by Hubbard et
al. (33). This clinical score was developed retrospectively in
a patient cohort undergoing evaluation for CAD as a
predictor of three-vessel or left main disease. The variables
included in this clinical score are male gender, history of
MI, diabetes, typical angina, and age. The score is weighted
for patients with advanced age and insulin-dependent dia-
betes. Poornima et al. (31) found that in their group of
patients with low DTSs, a low clinical score was associated
with an excellent seven-year survival regardless of the extent
of perfusion abnormalities on MPI expressed as a global
stress score. For example, the seven-year survival was 99% in
patients with normal scans, 99% in patients with mildly
abnormal scans, and 99% in patients with severely abnormal
scans with this combination. In contrast, patients with a
high clinical score in this group of patients with a low
pretest likelihood of CAD had a survival rate of 94% for
patients with normal scans, 94% for patients with mildly
abnormal scans, and 84% for patients with severely abnor-
mal scans. They concluded that in patients with low-risk
DTSs and a high clinical score, with an annual cardiac
mortality of 1%, MPI had independent prognostic value.
In patients with low-risk DTS and a low clinical risk score,
MPI was of limited prognostic value.
One possible limitation of the strategy proposed by
Poornima et al. (31) is the observation that only 3% of their
patient population had 1.0 mm of exercise-induced ST-
segment depression. Yet, 28% had moderately abnormal or
severely abnormal scans. Also, of the entire group of 1,461
patients, 1,158 (79%) had a low clinical score and would not
have been referred for subsequent testing with MPI. The
prevalence of exercise-induced ST-segment depression of
1.0 mm was 3% in these low clinical score patients,
whereas the prevalence of an abnormal scan was 24%. If one
assumes that half of the patients with low clinical scores and
ST-segment depression had true-positive ECG responses
for ischemia and thus would most likely be referred for
catheterization, this would leave 255 patients with moder-
ately or severely abnormal scans without ST-segment de-
pression who might have the diagnosis of CAD missed.
This highlights the difference between performing a test for
diagnostic indications and performing the test for assessing
prognosis. In patients with low DTSs and low clinical
scores, prognosis is excellent. Nevertheless, 20% would
not have their CAD detected.
The report by Hachamovitch et al. (32) in this issue of
the Journal examines a group of patients with a high
probability of CAD before any diagnostic testing. These are
patients without previous MI or revascularization who are
judged to have 85% pretest likelihood of CAD based on
age, gender, character of the chest pain syndrome, and
CAD risk factors. Myocardial perfusion imaging in this
patient population may be superfluous for CAD detection
because the assumption is that they have CAD and even a
normal perfusion scan would not have sufficient statistical
weight to adequately rule out CAD in patients with such a
high pretest likelihood. Myocardial perfusion imaging can,
however, be used to risk stratify these patients. Previous
studies have suggested that even patients with angiographic
CAD and normal or low-risk MPIs are at low risk of
subsequent cardiac events with medical management (34).
In an earlier study, Hachamovitch et al. (14) showed that
patients with high DTSs and normal scans had a 1.4% hard
event rate per year compared with a 9% event rate in
patients with moderately or severely abnormal scans and
high DTSs. In the study by Shaw et al. (16), which reported
a cohort of 3,620 medically treated patients of whom 42%
were female, more than 50% of patients with high DTSs
had a normal perfusion scan. They had an annual cardiac
death rate of 0.4% per year. In patients with high DTSs and
high-risk scans showing defects in three vascular territories,
there was a 10-fold higher annual cardiac death rate of
4.0%/year. Thus, MPI is able to further risk-stratify patients
with a high probability of CAD after exercise ECG stress
testing.
In the current article by Hachamovitch and colleagues
(32), 1,270 consecutive patients with a pre-exercise stress test
likelihood of ischemia of 85% were examined; 38% had
adenosine stress imaging. Patients with normal MPI had a
0.6% mortality rate per year and a 1.3% combined death and
nonfatal infarction rate per year. With increasing extent and
severity of perfusion abnormalities, the risk of both cardiac
mortality and combined events increased significantly. The
authors found that the addition of the MPI data resulted in
incremental prognostic value over pre-nuclear variable data.
With respect to cost-effectiveness, the authors show that
initial referral to MPI in this group of patients with a high
pretest likelihood was more cost-effective than initial refer-
ral to either treadmill exercise testing or cardiac catheter-
ization. They conclude that their results support the strategy
of initial stress imaging in this high pretest-probability
patient population, rather than direct referral to catheter-
ization for coronary angiography or starting with treadmill
exercise testing, as the first testing strategy.
Some limitations of both of these studies (31,32) deserve
mention. First, neither study uniformly examined functional
variables that are now easily measured from quantitative
gated SPECT. The limitation may not be great, because the
prevalence of CAD and previous infarction (the most
common cause for a depressed LVEF and CAD) was
probably quite low. In both studies, most patients had a
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normal resting ECG. The Hachamovitch study (32) ex-
cluded patients with previous MI, and the study by
Poornima et al. (31) comprised only those with low DTSs,
although some did have a previous MI (12%). Several
studies have shown that the prevalence of high-risk CAD is
enhanced when functional variables, such as extent of
regional wall motion or thickening abnormalities and rest-
ing LVEF, are obtained (21–25). This may be more relevant
to the study by Hachamovitch et al. (32) in that some
patients with extensive and diffuse CAD may have a normal
perfusion pattern secondary to balanced ischemia or globally
abnormal flow reserve (35) but have abnormal function
because of hibernation or stunning. Thus, the addition of
function variables would be expected to improve the sepa-
ration of high- and low-risk subsets of patients with high
pretest probability of CAD.
An interesting finding in the Hachamovitch et al. (32)
study was the 47% prevalence of normal scans in their
cohort of patients with 85% pretest likelihood of CAD.
Ninety-five percent of the patients had typical angina; 56%
had hypertension, and 48% had hyperlipidemia. Nearly 20%
had diabetes. Thus, it is surprising that almost half of the
patients judged to have a very high probability of CAD had
normal scans. This finding highlights the poor predictive
value of “typical angina” for predicting underlying ischemia.
In summary, these evidence-based studies by Poornima et
al. (31) and Hachamovitch et al. (32) refine further our
decision-making algorithms for use of radionuclide imaging
in evaluating patients with suspected CAD and offer a
rational basis for modifying practice guidelines. Patients
with low-risk treadmill tests but high-risk clinical variables
benefit from further noninvasive risk stratification with
exercise MPI. Patients with a high pretest likelihood of
CAD before any diagnostic testing benefit from undergoing
stress SPECT imaging for further risk stratification rather
than being referred directly for cardiac catheterization.
Although clinical science is a good basis for policy for
guidelines generation, practicing clinicians appreciate that
individual patients can vary greatly from the average of their
respective populations. The art and skill of medicine is the
ability to recognize variants and to treat patients as individ-
uals. While we strive to establish better evidence-based
guidelines for deciding whether to refer patients for diag-
nostic testing and/or medical therapy versus coronary revas-
cularization, we must continue to be aware of the limitations
of population averages and correlations and continue to
permit clinical experience and wisdom to play an appropri-
ate role in medical management decisions.
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